Porous solid phase for rapidly isolating biological molecules for nucleic acid amplification reaction from biological sample, and use thereof
10837010 ยท 2020-11-17
Assignee
Inventors
- Daeho Park (Yongin-si, KR)
- Junsung Shin (Goyang-si, KR)
- Jung-Heon Han (Anyang-si, KR)
- Guem Suk In (Siheung-si, KR)
- Jeong Soo Kim (Andong-si, KR)
Cpc classification
C01F7/02
CHEMISTRY; METALLURGY
C12Q1/6806
CHEMISTRY; METALLURGY
C12Q1/6806
CHEMISTRY; METALLURGY
C12N15/1006
CHEMISTRY; METALLURGY
International classification
C01F7/02
CHEMISTRY; METALLURGY
C12N15/10
CHEMISTRY; METALLURGY
C12Q1/6806
CHEMISTRY; METALLURGY
Abstract
A method for rapidly isolating a biological molecule for a nucleic acid amplification reaction from a biological sample, the method comprising: putting a cubical shaped-porous solid phase having a plurality of pores varied in size in contact with a biological sample to get the biological molecule present in the biological sample sucked into pores of the cubical shaped-porous solid phase, wherein the cubical shaped-porous solid phase is made of ceramic having oxide material, which is selected from the group consisting of Al2O3, Fe2O3, low temperature co-fired ceramic (LTCC), PbO, and ZnO.
Claims
1. A method for rapidly isolating a biological molecule for a nucleic acid amplification reaction from a biological sample, the method comprising: physically contacting a cubical shaped-porous solid phase having a plurality of pores varied in size with a biological sample; physically sucking the biological molecule present in the biological sample into the plurality of pores of the cubical shaped-porous solid phase to prepare a polymerase chain reaction (PCR) template, wherein the cubical shaped-porous solid phase is made of ceramic having oxide material, which is selected from the group consisting of Al2O3, Fe2O3, low temperature co-fired ceramic (LTCC), PbO, and ZnO, wherein, the Al2O3, has a temperature of 1450 C.-1550 C., the Fe2O3 has a temperature of 850 C.-900 C., the LTCC has a temperature of 750 C.-850 C., the PbO has a temperature of 1000 C.-1250 C., and the ZnO has a temperature of 900 C.-1000 C.; adding the PCR template into a tube for a PCR; and isolating the biological molecule for the nucleic acid amplification reaction from the biological sample without using a chemical buffer which reacts to the biological molecule.
2. The method of claim 1, wherein the biological sample is derived from an animal, a plant, a bacterium, or a fungus.
3. The method of claim 1, wherein the biological molecule is DNA, RNA, dsRNA, microRNA, viroid, virus, bacteria, fungi or microalgae.
4. The method of claim 1, wherein the porous solid phase is in the shape of a cube, a cuboid, a sphere, a cylinder, a bar, a bar with a dent at one end or a bar with a sharp end.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
DETAILED DESCRIPTION
(15) In order to accomplish the object of the present invention, the present invention provides a method for rapidly isolating biological molecules for a nucleic acid amplification reaction from a biological sample including putting a porous solid phase in contact with a biological sample, in which biological molecules of interest are sucked into the pores of the porous solid phase.
(16) In a method according to an embodiment of the present invention, the biological samples may be derived from an animal, a plant, a bacterium, or a fungus, and preferably, may be a plant or an animal, but is not limited thereto.
(17) In the present invention, the method of putting a porous solid phase in contact with a biological sample refers to a method to induce the absorption of the biological sample into the porous solid phase via a simple contact when the type of the biological sample is a liquid phase, and to keep the biological molecules released when cells are disrupted by pressing the porous solid phase with a flat portion on the rear side of metal tweezers when the type of the biological sample is a solid phase, but is not limited thereto.
(18) In an embodiment of the present invention, the biological molecules may be DNA, RNA, dsRNA, microRNA, viroid, virus, bacteria, fungi or microalgae, but is not limited thereto.
(19) The biological molecules of the present invention may be obtained from various sources in the case of an animal, for example, muscles, epidermis, blood, bones, and organs, and most preferably from muscles or blood, but is not limited thereto. In the case of a plant, the biological molecules may be obtained from various organ extracts, for example, leaves, flowers, stems, roots, fruits, and seeds, and most preferably from leaves, seeds or flowers, but is not limited thereto. In the case of microorganisms, the biological molecules may be obtained from colonies, mycelia or ooze, and most preferably from the sites with a dense habitation (the areas with lesions), but is not limited thereto. In the case of virus, bacteria, fungi, or microalgae, the analysis of a target gene is possible by putting the porous solid phase, where the size of their pores are appropriately adjusted, into contact, sucking partial particles or entire cells into the pores, and performing a PCR reaction using them as a template, thereby releasing the nucleic acids therein by the tissue destruction at high temperature denaturation step (about 94 C. to 96 C.) during the PCR reaction.
(20) The biological molecule of the present invention may also include nucleotides, which are the basic constitutional unit of nucleic acids, and its analogues with modified bases.
(21) In the method of the present invention, when the isolated biological molecule is gDNA it may be sucked by allowing a front end of a ceramic rod to contact with the biological sample. When the starting material is mRNA a front end of a ceramic rod is allowed to contact with the biological sample, and cDNA is synthesized using the total RNA adsorbed onto the front end as a template with reverse transcriptase. Since the total RNA is the one isolated from a plant or animal cell, there is a poly-A tail at the end of the mRNA, and cDNA can be easily synthesized using an oligo dT primer and a reverse transcriptase based on the characteristics of the sequence. Additionally, in the case of a virus, when there is a poly-A tail, cDNA can be synthesized in the same manner as described above, however, when the poly-A is absent (for example, tobacco mosaic virus), cDNA can be synthesized using a target RNA-specific antisense primer according to a method known in the art.
(22) In the method of the present invention, the above small amount of biological molecule may be applied to various methods known in the art where it can be used as a template. For example, the technologies to be applied in the present invention may include CAPS or SCAR molecular marker, HRM using a fluorescent marker, real time PCR, Nested PCR, immunocapture PCR, a multiplex PCR used for concurrently detecting various pathogens, direct determination of DNA sequences, single-stranded confirmation analysis (Orita et al., PNAS, USA 86:2776(1989)), RNase protection analysis (Finkelstein et al., Genomics, 7:167(1990)), Denaturing Gradient Gel Electrophoresis (Wartell et al., Nucl. Acids Res., 18:2699(1990)), a method using a protein capable of recognizing nucleotide mismatches (e.g., mutS protein of E. coli) (Modrich, Ann. Rev. Genet., 25:229-253 (1991)), allele-specific PCR, but is not limited thereto.
(23) When a nucleic acid amplification technology is applied, it is important to design an appropriate primer for virus detection of the present invention. However, the amount of the template amplification can be increased when RT and PCR are performed separately in two different tubes rather than when they are performed in the same tube, thereby improving the reliability of virus verification results. According to a preferred embodiment of the present invention, there is provided a method for analyzing the presence/absence of virus within tissues using a genotyping primer designed to be matched with nucleotides sucked into the ceramic block.
(24) The nucleic acid amplification of the present invention can be used for the manufacture of DNA molecular markers, construction of probes, construction of cDNA and genomic DNA libraries, inspection of pathogens, but is not limited thereto.
(25) In a method according to an embodiment of the present invention, the above nucleic acid amplification reaction may be via cDNA synthesis, polymerase chain reaction (PCR), multiplex PCR, reverse transcriptase polymerase chain reaction (RT-PCR), ligase chain reaction, nucleic acid sequence-based amplification, transcription-based amplification system, strand displacement amplification or amplification using Q replicase, or any method suitable for amplifying nucleic acid molecules known in the art. In the above, PCR refers to a method of amplifying a target nucleic acid from a primer pair specifically binding to target nucleic acid using a polymerase. These PCR methods are well known in the art, and a commercially available kit may be also used.
(26) In a method according to an embodiment of the present invention, the porous solid phase is at least one selected from the group consisting of carbonized cellulose, paper crumpled in a particulate form, natural or synthetic zeolite, polystylene, polycarbonate, polyprophylene, porous metal particle, porous rubber, microporous glass held together in a particle form, lime, a shell, a ceramic fragment, or ceramic of oxide material, and preferably a ceramic of oxide material, but is not limited thereto.
(27) In a method according to an embodiment of the present invention, the ceramic of oxide material may be a ceramic prepared using Al.sub.2O.sub.3, Fe.sub.2O.sub.3, LTCC (Low Temperature Co-fired ceramic), PbO or ZnO as main ingredients, but is not limited thereto.
(28) In a method according to an embodiment of the present invention, the porous solid phase may be in the shape of a cube, a cuboid, a sphere, a cylinder, a bar, a bar with a dent at one end and a sharp end, or a bar with a dent at one end and a sharp end and a large pore inside the sharp end, but is not limited thereto.
(29) When the ceramic of oxide material is used as a porous solid phase of the present invention its pore size can be adjusted. When a porous ceramic is manufactured using the same oxide material the size and number of pore can be adjusted according to the manufacturing temperature, and thus PCR or RT-PCR can be effectively performed using the optimized porous ceramic according to the type of biological molecules to be targeted. Regarding the pore size of such porous ceramic, the size of the porous solid phase may be appropriately adjusted so that it can selectively suck the targeted biological molecules. Additionally, although the external size of the above oxide material is not particularly limited if the ceramic can easily introduced into a PCR tube, for example, it may be 1 mm.sup.3, but is not limited thereto.
(30) Also, the present invention provides a method for amplifying a target sequence in a biological sample including:
(31) (a) putting a porous solid phase in contact with a biological sample, in which biological molecules of interest are sucked into the pores of the porous solid phase; and
(32) (b) adding the porous solid phase, into which the biological molecules in step (a) were sucked, as a template for a nucleic acid amplification reaction, and performing the amplification reaction using a target primer set, to amplify the target sequence.
(33) In an embodiment of the present invention, the above nucleic acid amplification method is the same as described above.
(34) Also, the present invention provides a method for amplifying a target sequence in a biological sample including:
(35) (a) putting a porous solid phase in contact with a biological samples in which biological molecules of interest are sucked into the pores of the porous solid phase; and
(36) (b) adding reverse transcriptase to the porous solid phase in step (a), into which the biological molecules were sucked, and performing a reverse transcriptase reaction; and
(37) (c) adding the reverse transcriptase reaction product as a template for a nucleic acid amplification reaction, and performing an amplification reaction using a target primer set thereby amplifying the target sequence.
(38) Also, the present invention provides a method for rapidly detecting the presence of a target sequence in a biological sample including:
(39) (a) putting a porous solid phase in contact with a biological sample, in which biological molecules of interest are sucked into the pores of the porous solid phase;
(40) (b) adding the porous solid phase in step (a), into which the biological molecules were sucked, as a template for a nucleic acid amplification reaction, and performing an amplification reaction using a target primer set to amplify the target sequence; and
(41) (c) detecting the amplified product.
(42) Also, the present invention provides a method for rapidly detecting the presence of a target sequence in a biological sample including:
(43) (a) putting a porous solid phase in contact with a biological sample, in which biological molecules of interest are sucked into the pores of the porous solid phase;
(44) (b) adding reverse transcriptase to the porous solid phase in step (a), into which the biological molecules were sucked, and performing a reverse transcriptase reaction;
(45) (c) adding the reverse transcriptase reaction product as a template for a nucleic acid amplification reaction, and performing an amplification reaction using a target primer set to amplify the target sequence; and
(46) (d) detecting the amplified product.
(47) The method of the present invention includes detecting the amplified product. The detection of the amplified product may be performed via DNA chips, gel electrophoresis, measurement of radioactivity, measurement of fluorescence, or measurement of phosphorescence, but is not limited thereto. As a method of detecting the amplified product, gel electrophoresis may be performed. According to the size of the amplified product, the gel electrophoresis to be used may be an agarose gel electrophoresis or acrylamide gel electrophoresis. Additionally, the method of fluorescent measurement can be carried out by performing a PCR reaction after labeling the 5-terminal with Cy-5 or Cy-3 so that a detectable target sequence is labeled as a fluorescence-labeled material and thereby the labeled fluorescence can be measured using a fluorimeter. Additionally, the method of radioactivity measurement can be carried out by adding a radioactive isotope such as .sup.32P or .sup.35S into a solution for PCR reaction when performing a PCR reaction so that the amplified product can be radiolabeled, and the radioactivity of the labeled amplified product can be measured using a radioactivity measuring device, for example, a Geiger counter or a liquid scintillation counter.
(48) Also, the present invention provides a kit for a nucleic acid amplification reaction for amplifying a target sequence in a biological sample including a porous solid phase capable of rapidly sucking biological molecules present in the biological sample into the pores of the porous solid phase; a target primer set; and a reagent for performing an amplification reaction.
(49) The kit for the nucleic acid amplification reaction may include reagents used for microRNA isolation, small RNA isolation, or cDNA synthesis, but is not limited thereto.
(50) In an embodiment of the present invention, the reagent for the nucleic acid amplification reaction may include DNA polymerase, dNTPs, buffers, etc. Additionally, the kit of the present invention may further include a user guide where the optimum conditions for performing the reaction are described. The user guide is, for example, a printed product which provides explanations on a method for preparing a PCR buffer, suggested reaction conditions, etc. The user guide should include explanations in a guide book such as a pamphlet or a leaflet, a label attached to a kit, and on the surface of a package containing the kit. Additionally, the user guide should include information being provided through an electric medium such as an internet
(51) In a kit according to an embodiment of the present invention, the nucleic acid amplification reaction may be cDNA synthesis, polymerase chain reaction (PCR), multiplex PCR or reverse transcriptase polymerase chain reaction (RT-PCR), but is not limited thereto. Additionally, the porous solid phase is the same as described above.
(52) Also, the present invention provides a kit for rapidly isolating biological molecules for a nucleic acid amplification reaction from a biological sample including a porous solid phase capable of rapidly sucking the biological molecules present in the biological sample into the pores of the porous solid phase.
(53) In a kit according to an embodiment of the present invention, the nucleic acid amplification reaction may be cDNA synthesis, polymerase chain reaction (PCR), multiplex PCR or reverse transcriptase polymerase chain reaction (RT-PCR), but is not limited thereto. Additionally, the porous solid phase is the same as described above.
(54) Additionally, the present invention provides a composition for rapidly isolating biological molecules for a nucleic acid amplification reaction from a biological sample including a porous solid phase capable of rapidly sucking the biological molecules present in the biological sample into the pores of the porous solid phase. The above composition includes a porous solid phase, into which biological molecules present in a biological sample of the present invention can be sucked, as an active ingredient, and by rapidly sucking the biological molecules present in a biological sample into the pores of the porous solid phase, it can be used for a nucleic acid amplification reaction. The porous solid phase is the same as described above.
(55) In a composition according to an embodiment of the present invention, the nucleic acid amplification reaction may be cDNA synthesis, polymerase chain reaction (PCR), multiplex PCR or reverse transcriptase polymerase chain reaction (RT-PCR), but is not limited thereto. Additionally, the porous solid phase is the same as described above.
(56) Hereinafter, the present invention will be described in more detail with reference to the following examples. However, the following examples are provided for illustrative purposes only, and the scope of the present invention should not be limited thereto in any manner.
Example 1. Adsorption of a Genetic Material Using a Porous Ceramic Cube and its Use as a Template for RT-PCR/PCR
(57) The adsorption of a genetic material using a porous ceramic cube of the present invention and a diagram illustrating its use as a template for RT-PCR/PCR is shown in
(58) The present invention, a single porous ceramic cube manufactured above was placed on top of a plant leaf, and pressed with a flat portion on the rear side of metal tweezers so that the genetic substance can be simultaneously sucked into the pores of the cube while the pressed tissues are burst, and the result of using the single cube into which the genetic substance was sucked as a template for RT-PCR or PCR was confirmed in an agarose gel (
Example 2. Isolation of a DNA/RNA Template for Nucleic Acid Amplification from a Biological Sample Using a Cut-Out Ceramic Fragment
(59) Seven kinds of cut-out ceramic fragments including blue and white porcelain was broken into small pieces using a nipper, and the fragments with a volume of about 1 mm.sup.3 selected from the unglazed area were used as an absorptive material for a genetic material. For the 5.sup.th ceramic fragment in
(60) As a result, as shown in
(61) Accordingly, in order to confirm to what extent each ceramic fragment can get the gDNA of pepper sucked and whether the sucked gDNA can be applied to PCR, the purified CM334 gDNA (1 g/L) was used as a material instead of leaves. The purified gDNA in an amount of 1 L was dropped onto the surface of a plastic petri dish, and the gDNA was sucked into each ceramic fragment, which was used as a template for PCR. As shown in
Example 3. Examination of an Absorption Rate of Biological Molecules According to the Types of Porous Ceramic Cubes of Oxide Material
(62) The picture of the surfaces of the respective porous ceramic cube manufactured using the oxide described in Table 1 as a main component enlarged under scanning electron microscope (SEM) is shown in
(63) TABLE-US-00001 TABLE 1 Main Manufacturing Sign Component Temperature ( C.) 1 Al.sub.2O.sub.3 1450 2 Al.sub.2O.sub.3 1550 3 Fe.sub.2O.sub.3 800 4 Fe.sub.2O.sub.3 850 5 Fe.sub.2O.sub.3 900 6 LTCC 650 7 LTCC 750 8 LTCC 850 9 PbO 1000 10 PbO 1150 11 PbO 1250 12 ZnO 800 13 ZnO 900 14 ZnO 1000
(64) {circle around (1)} Regarding Total RNA Isolated from CMV-Infected Capsicum annuum CM334 Pepper Leaves and Genomic DNA Isolated from CM334 Pepper
(65) In order to examine the absorption efficiency of biological molecules according to the type of porous ceramic cubes comprised of oxide material, the total RNA isolated from CMV-infected pepper leaves and genomic DNA isolated from CM334 pepper were sucked into each ceramic cube, and used as a template for RT-PCR and PCR, respectively. For CMV, a sense primer (5-TACATTGAGTCGAGTCATG-3: SEQ ID NO: 6) and an antisense primer (5-TGGAATCAGACTGGGACA-3: SEQ ID NO: 7) were respectively added at a concentration of 25 pmol to an RT-PCR premix, and amplified under the set conditions 50 C./20 min, 94 C./10 min, (94 C./30 sec, 55 C./30 sec, 72 C./60 sec) for 35 amplification cycles, 72 C./5 min, and electrophoresed on a 1% agarose gel containing EtBr, and the presence/absence of the target PCR product (670 bp) was confirmed (
(66) {circle around (2)} Regarding CMV-Infected Pepper Leaves and Purified CMV Particles
(67) In order to examine the absorption efficiency of biological molecules according to the type of the porous ceramic cubes, the CMV-infected pepper leaves and CMV particles were sucked into ceramic cubes and used as templates for RT-PCR and PCR. For CMV, a sense primer (5-TACATTGAGTCGAGTCATG-3: SEQ ID NO: 10) and an antisense primer (5-TGGAATCAGACTGGGACA-3: SEQ ID NO: 11), as a CMV particles-specific primer set, were added respectively at a concentration of 25 pmol to RT-PCR premix (RPampl, Biocubesystem, Korea), and reacted under the conditions of 50 C./20 min, 94 C./10 min, (94 C./30 sec, 55 C./30 sec, 72 C./60 sec) 35 amplification cycles, and 72 C./5 min, and the resultant was electrophoresed on a 1% agarose gel containing EtBr, and the presence/absence of the target PCR product (670 bp) was confirmed. When the purified virus was sucked into a porous ceramic cube there was a higher amplification in the PCR product but the PCR product amplification feature between the two treated sections were similar (
(68) {circle around (3)} Sucking Rate of Biological Molecules According to Manufacturing Temperature and Material of the Porous Ceramic Cube
(69) In
(70) {circle around (4)} Analysis of Pepper DNA Amplification Efficiency Using Porous Ceramic Cubes
(71) A single porous ceramic cube was placed on top of a Capsicum annuum sr10 pepper leaf, pressed with a flat portion on the rear side of metal tweezers to get gDNAsucked thereinto, and the resultant was added into a PCR tube, one per each tube. The solution for PCR reaction was prepared by adding 0.5 L of 10 pmol sense primer (Primer 10-F: 5-TGGCTTATCGAAGGAGCCAT-3: SEQ ID NO: 12), 0.5 L of 10 pmol antisense primer (Primer 10-R: 5-AGATGAAACCAAAGCCTCCA-3: SEQ ID NO: 13), a cube with gDNA, and 9 L of DW to 10 L to a 2PCR premix (gDamp1, Biocubesystem, Korea), and that for a positive control group was prepared by adding 2 L of purified gDNA (20 ng/L) and 7 L of DW instead of a cube. The PCR product was denatured at 94 C. for 3 minutes, amplified under the set conditions (94 C./30 sec, 58 C./30 sec, 72 C./60 sec) via 35 amplification cycles, and reacted at 72 C./5 min, and the resultant was electrophoresed on a 1% agarose gel containing EtBr, and confirmed whether the PCR product was amplified. As a result, Lane 5 (Fe.sub.2O.sub.3, 900 C.), Lane 8 (LTCC, 850 C.), Lane 9 (PbO, 1000 C.), Lane 10 (PbO, 1150 C.) and Lane 14 (ZnO, 1000 C.) showed good amplifications, whereas Lane 6 (LTCC, 650 C.), Lane 7 (LTCC, 750 C.) and Lane 8 (LTCC, 850) and Lane 12 (ZnO, 800 C.), Lane 13 (ZnO, 900 C.) and Lane 14 (ZnO, 1000 C.) were apparently distinguished according to the manufacturing temperature (
Example 4. LTCC Porous Cubes According to Manufacturing Conditions
(72) {circle around (1)} Effect of Manufacturing Temperature of LTCC Porous Cubes on PCR Amplification
(73) Upon repeated experiments, there was a distinct difference in gDNA amplification according to manufacturing temperature in LTCC material rather than ZnO (
(74) Referring to
(75) {circle around (2)} Surfaces (A-E) and Internal Cross-Sections (F-J) of LTCC Porous Ceramic Cubes According to Manufacturing Temperature
(76) In order to examine the characteristics of cubes according to their manufacturing temperature, 5 kinds of LTCC porous ceramic cubes were manufactured and their surfaces (
(77) {circle around (3)} Analysis of Material Sucking Capacity and Filtrating Capacity of LTCC Porous Cubes According to Manufacturing Temperature
(78) The decrease in the number of pores may be understood as the decrease in molecule sucking capacity, but in order to obtain more accurate data, the sucking capacity and filtration capacity were examined using a mixed liquid between artificially manufactured gold nanoparticles (average diameter: 40 nm) and polystylene particles (average diameter: 2 m, 5 m, 38-45 m, Beads & Micro, Korea). 10 cubes manufactured at the same temperature were impregnated per 20 l, of the above mixed liquid of the two different materials with different diameters, and the filtrate was completely removed using a micropipette and a filter paper. After adding 10 l, of sterile water to the same tube, the resultant was left at 65 C. for 30 minutes, vortexed for 10 seconds, and the surface characteristics of the remaining cubes and the particle distribution of the washing liquid were observed (5000 under SEM, and 250 under TEM).
(79) The observation of the cube surfaces under 5000 revealed that particles with a size similar to that of the pores easily observed in
(80) The results shown in
(81) {circle around (4)} Effect of Cube Surfaces on Amplification Efficiency of PCR Products
(82) The effects of surface roughness and number of pores on the amount of biological molecules sucked (i.e., gDNA) were examined. The surfaces of cube 33 (LTCC, 800 C.) having the best DNA amplification result were abraded for 48 hours and 72 hours, and their surface characteristics and PCR amplification efficiencies were compared.
(83) A single porous ceramic cube was placed on top of a pepper leaf, pressed with a flat portion on the rear side of metal tweezers, and the resultant was added into a PCR tube, one per each tube. The solution for PCR reaction was prepared by adding 0.5 L of 10 pmol sense primer, 0.5 L of 10 pmol antisense primer, a cube keeping gDNA, and 9 L of DW to 10 L to a 2PCR premix (gDamp1, Biocubesystem, Korea), and that for a positive control group was prepared by adding 2 L of purified gDNA (20 ng/L) and 7 L of DW instead of a cube. The PCR product was denatured at 94 C. for 3 minutes, amplified under the set conditions (94 C./30 sec, 58 C./30 sec, 72 C./60 sec) via 35 amplification cycles, and reacted at 72 C./5 min, and the resultant was electrophoresed on a 1% agarose gel containing EtBr, and confirmed whether the PCR product was amplified.
(84) Upon examination of the surface of each cube, the surface roughness was shown to increase in the order of 48 hours, 72 hours, and 0 hour, and the number of pores in the group treated for 48 hours was less than those in other treated groups. The examination of DNA amplification efficiencies of the above samples using primers 10 and 146 for PCR revealed that the PCR amplification efficiency of the group abraded for 48 hours was lower than the groups without abrasion, but the amplification efficiency of PCR product of the group abraded for 72 hours was similar to or slightly higher (
(85) From the above results, it was confirmed that manufacturing temperature can influence the surface characteristics of cubes in the roughness, area, and pore size. Additionally, it was determined that the change in cube characteristics according to the manufacturing temperature can influence the total sucking amount of reaction inhibitors and a template for PCR in the step of brining a porous solid phase into contact with a biological sample to get the biological molecules present in a biological sample (herein, gDNA or a nucleus) sucked into the pores of the porous solid phase. However, the most important change in the characteristics is that the manufacturing temperature can selectively remove PCR inhibitors by adjusting the number or size and surface areas of pores present in a porous cube, and also have a great influence on obtaining a sufficient amount of the initial template required for PCR.
Example 5. Multiplex RT-PCR Using Biological Molecules Isolated from Multiple-Infected Tobacco Leaves Using an LTCC Cube of the Present Invention
(86) N. benthamiana was subjected to a multiple infection of Cucumber mosaic virus (CMV) and Clover yellow vein potyvirus (ClYVV) and allowed proliferation of the viruses. Then, a single porous ceramic cube (33, LTCC, 800 C.) was placed on top of the multiple-infected tobacco leaf, pressed with a flat portion on the rear side of metal tweezers, and allowed the biological molecules (virus particles or an intermediate form of a virus) to be sucked into a cube. The cube absorbed with a template was added into a tube, one per each tube, and a RT-PCR reaction liquid was dispensed. For the detection of each virus alone, the RT-PCR reaction liquid was prepared by adding 1 L of 10 pmol sense primer, 1 L of 10 pmol antisense primer, a cube keeping the template, and 18 L of DW to a RT-PCR premix (RTamp1, Biocubesystem, Korea). For a multiplex RT-PCR, the solution was prepared by adding the primer for the corresponding virus as described above, and further added with 6 L of DW. The PCR product was denatured at 94 C. for 3 minutes, amplified under the set conditions (52 C./20 min, 94 C./30 sec, 68 C./30 sec, 72 C./60 sec) via 35 amplification cycles, and reacted at 72 C./5 min, and the resultant was electrophoresed on a 1% agarose gel containing EtBr, and confirmed whether the target PCR product was amplified. The primers used in the RT-PCR for CMV were DPU1 sense primer (5-CGTCGTGGTTCCCGCTCCG-3: SEQ ID NO: 16) and DPd2 antisense primer (5-AGCGCGCATCGCCGAAAGAT-3: SEQ ID NO: 17), and the primers used for ClYVV were 2F sense primer (5-TAAGAGAGGGGCACAGTGGA-3: SEQ ID NO: 18) and 2R antisense primer (5-GCAACAGCACGGGTAACA-3: SEQ ID NO: 19). The result in
Example 6. BAC Plasmid Amplification Using LTCC Cube of the Present Invention in E. coli
(87) Upon analysis, the porous ceramic cube was suggested to have both absorption capacity and filtration capacity, and the capacities were confirmed by sucking a bacteria culture into a cube and using the resultant as a template for PCR to see whether the PCR was successfully performed. A BAC colony was inoculated using a sterile toothpick into 5 ml of a liquid medium for culturing E. coli, and 1 L, 2 L, 3 L, and 4 l, of E. coli culture cultured for 15 hours was used as templates of a positive control. A wrap was laid flat on an experiment bench, aliquoted with 10 l, of E. coli culture thereon, and one, two, three and four porous ceramic cubes (34, LTCC, 850 C.) were added thereto to allow E. coli culture to be sucked into the porous ceramic cubes (34, LTCC, 850 C.). The cubes keeping the E. coli culture was picked up using metal tweezers, and the liquid remaining on the tweezers was removed using a tissue, and each of the cubes was inserted into a PCR tube and added with a PCR reaction liquid. The PCR reaction liquid was prepared by adding 1 l, of 10 pmol sense primer (Primer: 5-GTCAAATCTGAGGACGCTATGTCT-3: SEQ ID NO: 20), 1 l, of 10 pmol antisense primer (Primer: 5-CACTATAGAGAACTAGGTATGTCGTTG-3: SEQ ID NO: 21), 1-4 cubes keeping template(s), and DW to a final volume of 20 L, to 10 l, to a 2PCR premix (gDamp1, Biocubesystem, Korea). The PCR product was denatured at 95 C. for 3 minutes, amplified under the set conditions (95 C./30 sec, 58 C./30 sec, 72 C./60 sec) via 30 amplification cycles, and reacted at 72 C./10 min, and the resultant was electrophoresed on a 1% agarose gel containing EtBr, and confirmed whether the target PCR product was amplified (
Example 7. Types of Usable Porous Ceramics for Absorption of Biological Molecules
(88) In the present invention, according to the purposes, a structure such as that shown in
(89) Additionally, the structures shown in the middle and on the right of